New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus

by V.V. Poltorak
Published 2016-05-01

The Eye as an Antecedent Symptom for Cardiovascular Disease in Patients with Diabetes Mellitus (Pathogenetic Aspect and Clinical Implementation)

by V.V. Poltorak
Published 2013-04-01

The Phenomenon of Ischemic Preconditioning: the Effect of Glucose Imbalance and Antidiabetic Therapy

by V.V. Poltorak
Published 2013-03-01

Brands and Generics: Criteria for Evaluating the Effectiveness

by V.V. Poltorak, V.V. Lipson
Published 2013-09-01

ORIGIN Trial (Background, Results)

by M.D. Tronko, V.V. Poltorak, LK Sokolova
Published 2013-02-01

Комбинированная терапия «метформин + глимепирид» у больных сахарным диабетом 2-го типа (молекулярные механизмы оптимизации реабилитирующего действия)...

by V.V. Poltorak, N.S. Krasova, M.Yu. Horshunskaia
Published 2015-02-01

Glycemic Memory as a Pathogenic Basis for Modern Antidiabetic Therapy Algorithm Forming

by V.V. Poltorak, N.S. Krasova, M.Yu. Gorshunskaya
Published 2014-04-01

Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 1. Pharmacokinetic and Pharmacodynamic Aspects

by V.V. Poltorak, N.A. Kravchun, M.Yu. Gorshunska
Published 2015-10-01

Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

by V.V. Poltorak, N.А. Kravchun, M.Yu. Gorshunska
Published 2015-11-01

Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)

by V.V. Poltorak, N.A. Kravchun, M.Yu. Gorshunskaya, N.S. Krasova
Published 2014-02-01